Immunological Potency of HIV-1 DNA Vaccine and Its Relationship to Immune Dosage

HAO Yan-ling,LI Ping,HE Yan-ping,SUN Hong-yan,FU Jing-jing,SHAO Yi-ming

DOI: https://doi.org/10.13200/j.cjb.2012.08.21.haoyl.016

2012-01-01

Abstract:Objective To investigate the immunological potency of HIV-1 DNA vaccine as well as the immune response induced by vaccine at various dosages.Methods Eighty BALB / c mice were randomly divided into 8 groups,10 for each.The mice in seven test groups were injected i.m.with DNA vaccine pENV at dosages of 3.125,6.25,12.5,25,50,100 and 200 μg respectively,while those in control group with 100 μg empty vector pDRVI1.0,for 3 times at intervals of 2 weeks.The serum antibodies of mice were determined by ELISA,based on which the antibody positive conversation rate was calculated.The T cell responses of mice in various groups were determined by ELISPOT,based on which the response rate was calculated.Results The antibody response levels showed significant difference in the mice immunized with 25 and 100 μg DNA vaccine pENV(P 0.05),while showed no significant difference in other high dosage(not less than 25 μg)groups,or in low dosage(less than 25 μg)groups(P 0.05).Generally significant differences were observed in antibody positive rates in various test groups(P 0.05).The cellular immune response levels showed no significant difference in high dosage groups(P 0.05),which were more stable than those in low dosage groups.Both the antibody and cellular response levels were positively related to the dosage of vaccine,of which those induced by 100 μg vaccine reached peak values.Conclusion The HIV-1 DNA vaccine at a dosage of 25 μg might be suitable for BALB/c mice.However,low dosages without significant difference might be more suitable for pre-clinical test or clinical trial.